Singapore Markets open in 2 hrs 3 mins

Danimer Scientific, Inc. (DNMR)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
0.8017+0.0264 (+3.41%)
At close: 04:00PM EDT
0.8001 -0.00 (-0.20%)
After hours: 06:31PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close0.7753
Open0.7850
Bid0.7906 x 800
Ask0.7924 x 1300
Day's range0.7418 - 0.8397
52-week range0.6000 - 3.6970
Volume341,242
Avg. volume939,945
Market cap91.587M
Beta (5Y monthly)1.51
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Business Wire

    Danimer Scientific Announces $20 Million Asset-Based Revolving Credit Facility

    BAINBRIDGE, Ga., April 22, 2024--Danimer Scientific, Inc. (NYSE: DNMR) (the "Company" or "Danimer Scientific"), a leading next generation bioplastics company focused on the development and production of biodegradable materials, announced today, that on April 19, 2024, it entered into an asset-based revolving credit and security agreement with Mountain Ridge Capital secured primarily by the Company’s accounts receivable and inventory.

  • Business Wire

    Danimer Scientific Announces Fourth Quarter and Full Year 2023 Results

    BAINBRIDGE, Ga., March 28, 2024--Danimer Scientific, Inc. (NYSE: DNMR) ("Danimer" or the "Company"), a leading next generation bioplastics company focused on the development and production of biodegradable materials, announced today financial results for its fourth quarter and full year, ended December 31, 2023.

  • Business Wire

    Danimer Scientific Announces Closing of $15 Million Registered Direct Offering

    BAINBRIDGE, Ga., March 25, 2024--Danimer Scientific, Inc. (NYSE: DNMR) (the "Company" or "Danimer Scientific"), a leading next generation bioplastics company focused on the development and production of biodegradable materials, today announced the closing of its previously announced registered direct offering for the purchase and sale of 15,000,000 shares of common stock (or common stock equivalent in lieu thereof) at a purchase price of $1.00 per share (or per common stock equivalent in lieu th